Trial · NCT07885878
Implementation of Shoulder School in Albania
NCT07885878, Not applicable, Not yet recruiting, University of Valladolid
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Implementation of Shoulder School in Albania. Trials, record NCT07885878. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885878
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Implementation of Shoulder School in Albania
- NCT number
- NCT07885878
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 50 participants, estimated
- Lead sponsor
- University of Valladolid
- Conditions
- Rotator Cuff Related Shoulder Pain
- Interventions
- Shoulder school, Standard Care (in control arm)
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain intensity measured with visual analogue scale | From enrollment through treatment completion and up to 3 months of follow-up | Visual analogue scale is a subjective pain intensity measurement tool in which subjects are asked to indicate their perceived pain intensity on a 10 cm line. Patients will be informed that the left end of the scale represents "no pain" and the right end represents "the worst pain imaginable." It will be explained that marking closer to the right corresponds to a higher score (10 cm) and greater pain, while marking closer to the left corresponds to a lower score (0 cm) and a better state of health. |
| Secondary | Disability measured with Disabilities of the Arm, Shoulder and Hand Questionnaire | From enrollment through treatment completion and up to 3 months of follow-up | The DASH questionnaire (Disabilities of the Arm, Shoulder and Hand) is a 30-item self-report tool used to measure upper extremity disability and symptoms. It evaluates a patient's ability to perform everyday activities using a 1-to-5 Likert scale for each question. The final score ranges from 0 to 100, where 0 represents no disability and 100 indicates severe disability. |
| Secondary | Quality of life measured with EuroQol 5-Dimensions 5-Levels | From enrollment through treatment completion and up to 3 months of follow-up | The EQ-5D-5L stands for EuroQol 5-Dimensions 5-Levels, a standardized questionnaire used to measure health-related quality of life. It evaluates five health dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is rated across five severity levels, ranging from "no problems" to "extreme problems." The tool also features a Visual Analogue Scale (EQ-VAS) for patients to rate their overall health from 0 to 100. |
| Secondary | Range of motion measured with inclinometer | From enrollment through treatment completion and up to 3 months of follow-up | The range of motion of the shoulder will be carried out using a digital inclinometer for the movements of flexion, abduction, internal and external rotation of the arm. |
| Secondary | Isometric strenght measured with isometric dynamometer (Lafayette 01655) | From enrollment through treatment completion and up to 3 months of follow-up | Isometric strength will be assessed using the isometric dynamometer model Lafayette 01655 for the movements of elevation of the arm, and internal and external rotation of the glenohumeral joint |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07885878
GET https://conductscience.org/api/trials/v1/NCT07885878/registered